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Mutations in C12orf57 Cause a Syndromic Form
of Colobomatous Microphthalmia
Fatema Zahrani,1 Mohammed A. Aldahmesh,1 Muneera J. Alshammari,1,2 Selwa A.F. Al-Hazzaa,1,3
and Fowzan S. Alkuraya1,4,*
Microphthalmia is an important developmental eye disorder. Although mutations in several genes have been linked to this condition,
they only account for a minority of cases. We performed autozygome analysis and exome sequencing on a multiplex consanguineous
family in which colobomatousmicrophthalmia is associated with profound global developmental delay, intractable seizures, and corpus
callosum abnormalities, and we identified a homozygous truncating mutation in C12orf57 [c.1A>G; p.Met1?]. In a simplex case with
a similar phenotype, we identified compound heterozygosity for the same mutation and another missense mutation [c.152T>A;
p.Leu51Gln]. Little is known about C12orf57 but we show that it is expressed in several mouse tissues, including the eye and brain.
Our data strongly implicate mutations in C12orf57 in the pathogenesis of a clinically distinct autosomal-recessive syndromic form of
colobomatous microphthalmia.Microphthalmia is a condition in which partially arrested
eye development results in a clinically recognizable small
globe size unilaterally or bilaterally.1 Embryologically,
the elongating optic stalk features a groove known as the
choroid fissure, which closes as the optic stalk forms the
optic cup, so a developmental arrest is expected to result
not only in a small eye but also in failure of fissure closure
and resultant coloboma.2–5 This is consistent with the clin-
ical observation of nonrandom association between the
two eye anomalies; one large epidemiological study on
microphthalmia showed that around 70% of affected
individuals have associated defects in fissure closure.6
Mechanisms that arrest eye development vary and include
both environmental and genetic causes(see References7,8
and GeneReviews in Web Resources). Genetic forms of
microphthalmia are particularly interesting because they
provide insight into the molecular network that controls
the development of this important sensory organ. For
instance, the mapping of Pax6 as the mutated gene in
the small eye mouse was a critical landmark in our under-
standing of eye development and revealed mechanisms
that are remarkably conserved from mammals down to
fruitflies.9
Both syndromic and nonsyndromic forms of micro-
phthalmia are known to exist, although the latter account
for the majority of cases (two-thirds). In humans, muta-
tions in several genes have been identified in individuals
with both forms of microphthalmia. Most of these muta-
tions were described as autosomal dominant (usually
de novo), but X-linked and autosomal-recessive forms
have also been reported. Known causes of autosomal-reces-
sive microphthalmia include mutations in FOXE3 (MIM
601094) (monoallelic mutations in this gene cause ante-
rior-segment dysgenesis), CHX10 (MIM 142993), PITX31Department of Genetics, King Faisal Specialist Hospital and Research Center,
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The Ame(MIM 602669) (monoallelic mutations in this gene cause
anterior-segment dysgenesis), RAX (MIM 601881), SIX6
(MIM 606326), and ODZ3 (MIM 610083).10–14
The high rate of consanguinity in the Saudi population
has been shown to unmask numerous pathogenic reces-
sive alleles that cause various birth defects, including
those that cause microphthalmia, and these are typically
amenable to homozygosity mapping approaches.13–15
We have previously shown the power of supplementing
these approaches with next-generation sequencing to
identify ODZ3 as a gene mutated in a family with auto-
somal-recessive microphthalmia.14 As part of our ongoing
effort to explore the full spectrum of autosomal-recessive
forms of microphthalmia in our population, we report
here the identification of an autosomal-recessive form of
colobomatous microphthalmia in which affected individ-
uals have the additional features of profound global
developmental delay, intractable seizures, and abnormal
development of the corpus callosum. We show that
affected members of this family harbor a homozygous
truncating mutation in C12orf57. Reassuringly, we also
identified an additional simplex case in an individual
with a similar phenotype and show that she is compound
heterozygous for that same truncating mutation and
another allele in trans. Our findings strongly support the
candidacy of C12orf57 as a gene that is mutated in
a distinct syndromic form of colobomatous microphthal-
mia in humans.
Family 1 consists of second-cousin parents with two
healthy and four affected children (the fourth was born
during the study) (Figure 1 and Table 1). The older affected
individual in this family is a 19-year-old male (VI:4). He
was born after an uneventful pregnancy. Seizures devel-
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Figure 1. Identification of Individuals with a Syndromic form of Colobomatous Microphthalmia
(A) Pedigree of Family 1.
(B) An MRI of individual VI:6 shows a normal corpus callosum.
(C) The corpus callosum is absent in individual VI:4.
(D) Thickened corpus callosum in individual VI:5.
(E) Facial photos of the index individual in family 2 (iris coloboma is evident in both eyes, particularly the right because of flash
reflection).generalized tonic clonic epilepsy. In addition, he has
profound global developmental delay. Physical examina-
tion revealed no obvious dysmorphism but did reveal
poor body build and hypertonia. Ophthalmological exam-
ination was significant for mild microphthalmia and
bilateral iridal and inferior chorioretinal coloboma that
extended to the optic disc and was associated with light
perception only. His brain MRI revealed agenesis of the
corpus callosum (Figure 1).Table 1. Summary of Clinical Features in Two Families Affected by a S
Individual ID Age Gender
Colobomatous
Microphthalmia GDDa
VI:4 19 years M yes (bilateral) yes
VI:5 18 years M yes (bilateral) yes
VI:6 12 years F no yes
VI:8 2.5 years M no yes
Family 2 6 years F yes (bilateral) yes
aGDD: Global developmental delay.
388 The American Journal of Human Genetics 92, 387–391, March 7The second affected child in this family (VI:5) is an
18-year-old male. Global developmental delay and poor
vision were apparent in infancy. Seizures developed at
2.5 years of age and continue to be refractory to multiple
antiepileptic medications. Physical examination revealed
hypertonia and bilateral chorioretinal coloboma involving
the optic disc, whereas the anterior segment appeared
normal. Apart from thickening of the corpus callosum,
his brain MRI was unremarkable.yndromic Form of Colobomatous Microphthalmia
Epilepsy
Corpus Callosal
Abnormality Others
yes yes (agenesis) Hypertonia, self-mutilation
and xylophagia
yes yes (hyperplasia)
yes no Hypertonia
yes yes (agenesis)
yes no
, 2013
The third affected child is a 12-year-old girl (VI:6). She
has had refractory epilepsy since the age of 6 months,
and she displays profound global developmental delay.
Ophthalmological examination revealed a normal anterior
segment and no clinical evidence of coloboma. Apart
from mild hypertonia and slightly increased reflexes,
her physical exam was unremarkable. A brain MRI was
unremarkable.
During the course of the study, a fourth affected child
(VI:8) was born and is now almost 2.5 years old. He devel-
oped seizures recently and showed only partial response to
carbamazepine. A limited ophthalmological examination
revealed no gross abnormalities. A brain MRI was signifi-
cant for corpus callosum agenesis.
None of the four affected siblings shows any evidence of
other system involvement. All underwent extensive
medical evaluation that included metabolic screening;
liver and renal function tests; a complete blood count; a
bone profile; and test showing that blood gases, ammonia,
and lactate levels were all within normal limits.
Parents signed a written consent to participate in an IRB-
approved research protocol (King Faisal Specialist Hospital
and Research Center RAC# 2070023) before blood was
drawn in EDTA tubes for DNA extraction. Genotyping
was performed on an Axiom platform according to the
manufacturer’s protocol (Affymetrix, Santa Clara, CA,
USA), and the full set of autozygosity blocks per individual
(autozygome) was determined by autoSNPa.16 One
member of family 1 (VI:5) underwent exome sequencing.
Exome capture was performed with the TruSeq Exome
Enrichment kit (Illumina, San Diego, CA, USA) according
to the manufacturer’s protocol. Samples were prepared as
an Illumina sequencing library, and in the second step,
the sequencing libraries were enriched for the desired
target with the Illumina Exome Enrichment protocol.
The captured libraries were sequenced with Illumina
HiSeq 2000 Sequencer. The reads were mapped against
UCSC hg19 with the Burrows-Wheeler Aligner (see Web
Resources). The SNPs and Indels were detected with
SAMTOOLS.
Although we did expect smaller or fewer runs of homo-
zygsity (ROH) in family 1 because parents were second
cousins, we could not identify any ROH that were
exclusively shared by the affected children even after we
lowered our threshold to just 1Mb (Figure S1). In view of
the apparent lack of an obvious lead from autozygome
analysis, we were unable to use it to filter the exome results
and instead used the following filters: total variants /
homozygous variants / variants that are absent in
dbSNP/ variants that are coding or splicing/ variants
that are predicted to be pathogenic / variants that are
absent in 200 in-house Saudi exomes. Nine variants
survived this filtration scheme, but only one passed the
segregation test (Figure S2 in the Supplemental Data avail-
able online). This variant in C12orf57 (RefSeq accession
number NM_138425.2: c.1A>G) abolishes the normal
initiation codon and is predicted to completely abolishThe Amethe protein because the next ATG is out of frame in all
three known protein-coding transcripts (Figure 2). When
we re-examined the autozygome data in this family, we
identified a very small (500 kb) run of homozygosity
encompassing this gene in the three genotyped siblings
(Figure S1). This represents a highly unusual sequence of
recombination events given that the affected individuals
are only four generations removed from the nearest
common ancestor.15,17 Indeed, the centromeric recombi-
nation was <70 kb away from the gene locus (Figure S1).
We then searched our database of >30 microphthalmia
families for potential clinical overlap and identified family
2, which consists of two young Saudi parents who belong
to the same tribe but deny identifiable consanguinity
otherwise. Their only child is a 6-year-old girl with
profound global developmental delay and epilepsy that
began at 6 months of age and is currently under control
after numerous trials of antiepilepsy medications. The
girl also has bilateral microphthalmia and coloboma
involving the iris, choroid, and retina and extending to
the optic cup (Figure 1 and Table 1). Her brain MRI was
unremarkable.
Subsequent direct sequencing of C12orf57 in family 2
revealed that the affected individual was compound
heterozygous for the same mutation as well as a previously
undescribed missense variant, c.152T>A [p.Leu51Gln].
Sequencing of the parents confirmed that the two muta-
tions are in trans in their affected daughter (Figure 2).
The p.Leu51Gln variant is predicted to be pathogenic
in silico (PolyPhen score of 0.997, SIFT score of 0.01, and
MutationTaster score of 1) and is highly conserved
(Figure S3). Like the p.Met1? substitution, p.Leu51Gln
was absent in EVS (exome variant server), 200 in-house
Saudi exomes, and 576 Saudi individuals (1552 Saudi
chromosomes) who underwent direct sequencing. In order
to address the possibility that C12orf57 is a gene that accu-
mulates pathogenic variants in the general population, we
fully sequenced the gene in 96 Saudi controls and found
no pathogenic variants.
Colobomatous microphthalmia affects around 10% of
blind children and is associated with significant morbidity
that is proportionate to the degree of severity.1,18 Most
children with this condition lack a definite molecular
diagnosis because the clinical presentation usually predicts
the likely genetic defect only in a subset of distinct
syndromic associations, as in the case of CHD7 (MIM
608892)- and BMP4 (MIM 112262)-related microphthal-
mia. In fact, the true contribution of Mendelian mutations
to the causation of this condition is very difficult to deter-
mine, especially in simplex cases, which account for the
majority of cases. Indeed, colobomatous microphthalmia
in family 2 could have been due to many causes, and we
were only able to identify the biallelic mutation in
C12orf57 through the study of family 1. Thus, although
the syndrome we describe here clearly has important
additional features, we believe that colobomatous micro-
phthalmia is the most helpful defining feature. However,rican Journal of Human Genetics 92, 387–391, March 7, 2013 389
Figure 2. Ensembl View Showing All Known C12orf57 Transcripts Drawn to Scale
The location of the p.Met1? mutation is indicated by a red dotted line showing that it affects the same start codon in all three coding
transcripts. The blue dotted line denotes the location of the p.Leu51Gln mutation. Sequence chromatograms are shown for both
mutations.as is typical of many other syndromes, even this feature is
not fully penetrant, and its absence does not exclude the
possibility of C12orf57 mutation.
Virtually nothing is known about C12orf57 other than
that it has recently been reported to be mutated in a family
described as having ‘‘nonsyndromicmental retardation.’’19
However, we show that affected members of that family
clearly display a distinct phenotype that consists of
profound delay in all aspects of development, early-onset
intractable seizures, an abnormal corpus callosum, and
50% penetrance of colobomatous microphthalmia. The
penetrance of colobomatous microphthalmia is increased
to 60% if we include family 2. Thus, C12orf57 must be
playing an important developmental role in both the brain
and eye, although the exact role remains unknown. Our
expression profiling in mice revealed ubiquitous expres-
sion, including in the brain and eye (Figure 3).
In summary, we add to the literature an autosomal-reces-
sive cause of colobomatous microphthalmia that seems to
be invariably associated with profound global develop-
mental delay and intractable early-onset seizures, as well
as occasional defects of the corpus callosum. We believe
that individuals with this syndromic from of coloboma-390 The American Journal of Human Genetics 92, 387–391, March 7tous microphthalmia should be screened for mutations
in C12orf57. Future studies are needed to understand the
role of this gene in a developmental context and to deter-
mine the minimal diagnostic criteria for this syndrome.Supplemental Data
Supplemental Data include three figures and can be found with
this article online at http://www.cell.com/AJHG/.Acknowledgments
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Figure 3. Expression Profiling of C12orf57 in the Mouse
Upper panel: Gel picture of RTPCR using RNA from various
mouse tissues (Gapdh is shown below as an internal control for
each reaction).
Lower panel: Bar chart summarizing the results of quantitative
RTPCR for the same tissues (error bars for the experimental tripli-
cates are shown).Web Resources
The URLs for data presented herein are as follows:
Burrows-Wheeler Aligner, http://bio-bwa.sourceforge.net/
Ensembl Genome Browser, http://www.ensembl.org/index.html
GeneReviews, Bardakjian, T., Weiss, A., and Schneider, A.S. (1993).
Anophthalmia/Microphthalmia Overview, http://www.ncbi.
nlm.nih.gov/books/NBK1378/
MutationTaster, www.mutationtaster.org/
Online Mendelian Inheritance in Man (OMIM), http://www.
omim.org
PolyPhen, www.genetics.bwh.harvard.edu/pph2/
SAMtools, http://samtools.sourceforge.net/
SIFT, http://sift.bii.a-star.edu.sg/
UCSC Genome Browser, http://genome.ucsc.edu/
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